Literature DB >> 1967482

Monoamine oxidase B and Parkinson's disease.

G Steventon, C Humfrey, S Sturman, R H Waring, A C Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1967482     DOI： 10.1016/0140-6736(90)90063-b

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Ecogenetics, xenobiotic biochemistry and neurological disease.

Authors:  A Williams
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

2.  Selegiline and the Treatment of Parkinson's Disease: How patients can benefit from drug therapy.

Authors:  J S Richardson
Journal:  Can Fam Physician       Date:  1991-05       Impact factor: 3.275

3.  Decreased beta-phenylethylamine in CSF in Parkinson's disease.

Authors:  G Zhou; H Shoji; S Yamada; T Matsuishi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

4.  Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.

Authors:  Maroof Husain; Rakesh Shukla; Madhu Dikshit; Pradeep K Maheshwari; Devika Nag; Rikhab C Srimal; Prahlad K Seth; Vinay K Khanna
Journal:  Neurochem Res       Date:  2009-03-04       Impact factor: 3.996

Review 5.  Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease.

Authors:  A C Williams; G B Steventon; S Sturman; R H Waring
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.